Novel diindolylmethane derivatives based NLC formulations to improve the oral bioavailability and anticancer effects in triple negative breast cancer-Reference-Cited by-同舟云学术

Novel diindolylmethane derivatives based NLC formulations to improve the oral bioavailability and anticancer effects in triple negative breast cancer

Published:2016-11 Issue: Volume:108 Page:168-179
ISSN:0939-6411
Container-title:European Journal of Pharmaceutics and Biopharmaceutics
language:en
Short-container-title:European Journal of Pharmaceutics and Biopharmaceutics

Author:

Godugu Chandraiah,Doddapaneni Ravi,Safe Stephen H.,Singh Mandip

Funder

Department of Defense (DOD) Breast Cancer ProgramDepartment of Defense (DOD) Breast Cancer Program

National Institute on Minority Health and Health Disparities (NIMHD) P20 programNational Institute on Minority Health and Health Disparities (NIMHD) P20 program

National Institutes of Health (NIH) SC-1 grantNational Institutes of Health (NIH) SC-1 grant

Publisher

Elsevier BV

Subject

Pharmaceutical Science,General Medicine,Biotechnology

Reference36 articles.

1. Progress in nanotechnology-based drug carrier in designing of curcumin nanomedicines for cancer therapy: current state-of-the-art;Ahmad;J. Drug Target.,2015

2. 1,1-Bis (3′-indolyl)-1-(p-substitutedphenyl)methane compounds inhibit lung cancer cell and tumor growth in a metastasis model;Andey;Eur. J. Pharm. Sci.,2013

3. Mechanism of transport of saquinavir-loaded nanostructured lipid carriers across the intestinal barrier;Beloqui;J. Control. Release,2013

4. Chemoprevention of skin cancer with 1,1-Bis (3′-indolyl)-1-(aromatic) methane analog through induction of the orphan nuclear receptor, NR4A2 (Nurr1);Boakye;PLoS ONE,2013

5. Nanomedicine applied to translational oncology: A future perspective on cancer treatment;Bregoli;Nanomedicine,2015

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhanced oral bioavailability and in vitro evaluation of cannabidiol camel milk-derived exosome formulation in resistant MDA-MB-231 and MDA-MB-468 breast cancer cells;International Journal of Pharmaceutics;2024-09

2. Leveraging nanostructured lipid carriers to enhance targeted delivery and efficacy in breast cancer therapy: a comprehensive review;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-08-28

3. Unlocking the Potential of Camel Milk-Derived Exosomes as Novel Delivery Systems: Enhanced Bioavailability of ARV-825 PROTAC for Cancer Therapy;Pharmaceutics;2024-08-15

4. Development of a self-nanoemulsifying drug delivery system of diindolylmethane for enhanced bioaccessibility, bioavailability and anti-breast cancer efficacy;Journal of Drug Delivery Science and Technology;2024-03

5. Chitosan coated lipid carriers as nanoplatform for repurposed anti-breast cancer activity of niclosamide;Journal of Drug Delivery Science and Technology;2024-03